Silence Therapeutics plc Accounts Payable, Other, Current
Silence Therapeutics plc (SLN) had Accounts Payable, Other, Current of $12.61 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accounts Payable, Current
us-gaap:AccountsPayableOtherCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Other, Current $12.61M.
- 2026-03-31: Accounts Payable, Other, Current $10.37M.
- 2025-12-31: Accounts Payable, Other, Current $13.36M.
- 2025-09-30: Accounts Payable, Other, Current $16.99M.
| Period end | Accounts Payable, Other, Current |
|---|---|
| 2026-06-30 | $12.61M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $10.37M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $13.36M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $16.99M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $14.31M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $18.81M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.40M 10-K · filed 2026-03-05 |
| 2023-12-31 | $15.54M 10-K · filed 2025-02-27 |